DOSSIER · 13F Holders · Q2 2026Healthcare · Biological Products, (No Diagnostic Substances)
EXEL
EXELIXIS INC
800 institutions still hold EXELIXIS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 30161Q104·Biological Products, (No Diagnostic Substances)·800 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
800 institutions reported EXEL in Q2 2026. BlackRock, Inc. leads at 18.2% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 40
780 more holders available. Log in →